ArticleYonsei medical journal2017

Administration of a High-Dose Erythropoietin-Stimulating Agent in Hemodialysis Patients is Associated with Late Arteriovenous Fistula Failure.

Hye Yun Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.